These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 20214748
41. Sirolimus as renal and immunological rescue agent in pediatric liver transplant recipients. Basso MS, Subramaniam P, Tredger M, Verma A, Heaton N, Rela M, Mieli-Vergani G, Dhawan A. Pediatr Transplant; 2011 Nov; 15(7):722-7. PubMed ID: 22004546 [Abstract] [Full Text] [Related]
42. An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency. Peddi VR, Jensik S, Pescovitz M, Pirsch J, Adler SH, Thistlethwaite JR, Vincenti F, Cohen DJ. Clin Transplant; 2005 Feb; 19(1):130-6. PubMed ID: 15659146 [Abstract] [Full Text] [Related]
43. Evaluation of the efficacy and safety of a slow conversion from calcineurin inhibitor- to sirolimus-based therapies in maintenance renal-transplant patients presenting with moderate renal insufficiency. Kamar N, Frimat L, Blancho G, Wolff P, Delahousse M, Rostaing L. Transpl Int; 2007 Feb; 20(2):128-34. PubMed ID: 17239020 [Abstract] [Full Text] [Related]
45. Sirolimus monotherapy effectiveness in liver transplant recipients with renal dysfunction due to calcineurin inhibitors. Di Benedetto F, Di Sandro S, De Ruvo N, Spaggiari M, Montalti R, Ballarin R, Cappelli G, Gerunda GE. J Clin Gastroenterol; 2009 Mar; 43(3):280-6. PubMed ID: 19057397 [Abstract] [Full Text] [Related]
46. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment. Uslu A, Töz H, Sen S, Alkan FT, Nart A, Aykas A, Doğan M, Postaci H, Sahin T, Simşek C. Transplant Proc; 2009 Mar; 41(2):756-63. PubMed ID: 19328973 [Abstract] [Full Text] [Related]
51. Efficacy of conversion to sirolimus in posttransplantation Kaposi's sarcoma. Gutiérrez-Dalmau A, Sánchez-Fructuoso A, Sanz-Guajardo A, Mazuecos A, Franco A, Rial MC, Iranzo P, Torregrosa JV, Oppenheimer F, Campistol JM. Transplant Proc; 2005 Nov; 37(9):3836-8. PubMed ID: 16386556 [Abstract] [Full Text] [Related]
54. The use of sirolimus as a rescue therapy in pediatric intestinal transplant recipients. Andres AM, Lopez Santamaría M, Ramos E, Hernandez F, Prieto G, Encinas J, Leal N, Molina M, Sarría J, Tovar J. Pediatr Transplant; 2010 Nov; 14(7):931-5. PubMed ID: 20946188 [Abstract] [Full Text] [Related]
55. Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment. Snell GI, Levvey BJ, Chin W, Kotsimbos T, Whitford H, Waters KN, Richardson M, Williams TJ. J Heart Lung Transplant; 2002 May; 21(5):540-6. PubMed ID: 11983543 [Abstract] [Full Text] [Related]